We enable new sciences.
The Precision Radio-Theranostics Translational Laboratories (PRT2L) is one of six research labs at Mallinckrodt Institute of Radiology at Washington University School of Medicine. We are known for developing imaging technologies that enable new sciences.
Our contributions began more than half a century ago with the use of positron-emitting radionuclides for biological research, followed by the development of the first Positron Emission Tomography (PET) scanner four decades ago. Our lab continues today as a global leader in the development of novel radiopharmaceuticals and molecular imaging technologies used to diagnose, assess and treat disease. We have developed and translated a broad range of radiotracers (17 IND and 20 RDRC) for cancer, neurodegenerative and cardiovascular research.
The PRT2L is an interdisciplinary research lab staffed by faculty with diverse backgrounds. They include chemistry, radiochemistry, nuclear chemistry, imaging physics, instrumentation, biomathematics and biomedical engineering. We partner with physicians and scientists within the university and with academia and industries across the world to advance patient care through innovations in molecular imaging agents and imaging technology.